Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome.
Saved in:
| Title: | Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. |
|---|---|
| Authors: | Acosta A; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA., Camilleri M; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA., Shin A; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA., Linker Nord S; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA., O'Neill J; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA., Gray AV; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA., Lueke AJ; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA., Donato LJ; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA., Burton DD; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA., Szarka LA; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA., Zinsmeister AR; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA., Golden PL; Salix Pharmaceuticals, Raleigh, North Carolina, USA., Fodor A; Bioinformatics/Computer Science, University of North Carolina-Charlotte, Charlotte, North Carolina, USA. |
| Source: | Clinical and translational gastroenterology [Clin Transl Gastroenterol] 2016 May 26; Vol. 7, pp. e173. Date of Electronic Publication: 2016 May 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101532142 Publication Model: Electronic Cited Medium: Print ISSN: 2155-384X (Print) Linking ISSN: 2155384X NLM ISO Abbreviation: Clin Transl Gastroenterol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27228404 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Acosta+A%22">Acosta A</searchLink>; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Camilleri+M%22">Camilleri M</searchLink>; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Shin+A%22">Shin A</searchLink>; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Linker+Nord+S%22">Linker Nord S</searchLink>; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22O'Neill+J%22">O'Neill J</searchLink>; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Gray+AV%22">Gray AV</searchLink>; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Lueke+AJ%22">Lueke AJ</searchLink>; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Donato+LJ%22">Donato LJ</searchLink>; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Burton+DD%22">Burton DD</searchLink>; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Szarka+LA%22">Szarka LA</searchLink>; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Zinsmeister+AR%22">Zinsmeister AR</searchLink>; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Golden+PL%22">Golden PL</searchLink>; Salix Pharmaceuticals, Raleigh, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Fodor+A%22">Fodor A</searchLink>; Bioinformatics/Computer Science, University of North Carolina-Charlotte, Charlotte, North Carolina, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101532142%22">Clinical and translational gastroenterology</searchLink> [Clin Transl Gastroenterol] 2016 May 26; Vol. 7, pp. e173. <i>Date of Electronic Publication: </i>2016 May 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%22">Wolters Kluwer Health </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532142 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2155-384X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222155384X%22">2155384X </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Gastroenterol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27228404 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/ctg.2016.32 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e173 Titles: – TitleFull: Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Acosta A – PersonEntity: Name: NameFull: Camilleri M – PersonEntity: Name: NameFull: Shin A – PersonEntity: Name: NameFull: Linker Nord S – PersonEntity: Name: NameFull: O'Neill J – PersonEntity: Name: NameFull: Gray AV – PersonEntity: Name: NameFull: Lueke AJ – PersonEntity: Name: NameFull: Donato LJ – PersonEntity: Name: NameFull: Burton DD – PersonEntity: Name: NameFull: Szarka LA – PersonEntity: Name: NameFull: Zinsmeister AR – PersonEntity: Name: NameFull: Golden PL – PersonEntity: Name: NameFull: Fodor A IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 05 Text: 2016 May 26 Type: published Y: 2016 Identifiers: – Type: issn-print Value: 2155-384X Numbering: – Type: volume Value: 7 Titles: – TitleFull: Clinical and translational gastroenterology Type: main |
| ResultId | 1 |